PTEN is a negative regulator of the phosphoinositide 3-kinase/AKT survival pathway, that exhibits strong tumor-suppressive activities, as the PI3K/AKT signaling pathways are activated by KRAS and EGFR mutations. This evidence concerns the gene AKT1 and neoplasm.